Funding Resources
Funding Overview
Funding Strategy
Funding Opportunities
Grant Mechanisms
Training & Career
Development
Contracts Management
Review Committees
Funding News |
Research
Anticonvulsant Screening
Program
Clinical Research
Counterterrorism
Epilepsy Research Web
Neural Interfaces Program
NIH Roadmap Research
Parkinson's Web
Resources for Scientists
Stem Cell Research
Translational Research
Traumatic Brain Injury
(TBI) Research
Technology Transfer
Office
NINDS is part of the
National Institutes of
Health
NINDS invites applications to develop new technology for proteomics and glycomics. This announcement is made together with 5 other NIH components and is supported by 2 funding mechanisms: SBIR and STTR.
Proteomics technologies and methods remain largely inadequate, particularly with respect to quantitative and real-time measurements. This announcement solicits small business research applications to develop broadly applicable research tools that address the core technical challenges in proteomics and glycomics. This includes, but is not restricted to, robotics, sample preparation and pre-fractionation, analytical separations, gel and array imaging, quantitation, mass spectrometry, intelligent automated data acquisition, and improved informatics technologies.
Potential applicants should contact Dr. Danilo Tagle, Program Director, Neurogenetics Cluster, NINDS; telephone: 301-496-5745; email: dt39y@nih.gov. For a more detailed description of this program announcement, visit http://grants.nih.gov/grants/guide/pa-files/PA-07-451.html or http://grants.nih.gov/grants/guide/pa-files/PA-07-452.html.
This content has been adapted from the original NINDS Notes publication. For the most up-to-date funding information, please visit the Funding Opportunities section of the NINDS web site. For the most recent information on NINDS studies, please visit the NINDS Patient Recruitment web site.